Overview
Fluticasone is a synthetic corticosteroid developed for its potent anti-inflammatory and immunosuppressive effects. It exists in two primary forms: fluticasone propionate and fluticasone furoate, each tailored for specific medical applications. The compound is a cornerstone in treating respiratory and dermatological conditions due to its ability to reduce inflammation with minimal systemic absorption. First introduced in the 1990s, fluticasone has become a key active ingredient in inhaled medications for asthma and chronic obstructive pulmonary disease (COPD). Its localized action minimizes side effects compared to oral corticosteroids, making it a preferred choice for long-term management of inflammatory conditions.
Physical and Chemical Properties
Fluticasone derivatives are characterized by their white crystalline powder form and low solubility in water. The propionate form melts at 272-274°C, indicating stability under typical storage conditions. Both variants are lipophilic, facilitating their absorption into target tissues like the lungs or skin. The molecular structure includes a fluorinated backbone, enhancing glucocorticoid receptor binding affinity. This design reduces the required dosage for therapeutic effects, lowering the risk of adverse reactions. Stability studies recommend protection from light and moisture to prevent degradation.
Main Applications
In respiratory medicine, fluticasone propionate is formulated as metered-dose inhalers (e.g., Flovent) to control asthma symptoms. The furoate variant is used in nasal sprays (e.g., Flonase) for allergic rhinitis, offering 24-hour relief with once-daily dosing. Topical creams (e.g., Cutivate) treat eczema and psoriasis by reducing skin inflammation and itching. Combination products like Advair pair fluticasone with bronchodilators (e.g., salmeterol) for enhanced COPD management. These applications leverage fluticasone’s localized potency while mitigating systemic exposure risks.
Safety and Storage
Prolonged use of fluticasone requires medical supervision to monitor for adrenal suppression or cataracts. Topical formulations may cause skin thinning or contact dermatitis in sensitive individuals. Proper storage at 2-8°C preserves stability, though some commercial products are stable at room temperature for limited periods. Workers handling raw fluticasone should use PPE to avoid inhalation or skin contact. Disposal must follow pharmaceutical waste regulations to prevent environmental contamination.
B2B Procurement Guide
Pharmaceutical manufacturers should prioritize suppliers with ISO 9001 or GMP certification to ensure purity (typically ≥98%). Batch-specific COAs must confirm identity (via HPLC) and residual solvent levels. Pricing varies by quantity, with bulk purchases (100+ kg) often discounted by 10-15%. Logistics require temperature-controlled transport for raw material stability. Importers should check regional regulations, as some countries restrict corticosteroid imports without prior authorization.
Related Manufacturers
- 主营：实验试剂、工具化合物、抗体抑制剂、重组蛋白
- 主营：抑制剂、化合物库、药物筛选、天然产物